Zuellig Pharma Korea, “We will help Korean pharmaceuticals to expand foreign markets”

Zuellig Pharma Korea announced a position to provide help for innovative pharmaceutical products developed by domestic pharmaceutical companies to enter foreign markets.

In fact, Zeullig Pharma Korea has played an essential role in establishing the license agreement of ‘Kanarb,’ a Boryung Pharm’s antihypertensive, in the 13 East Asian countries last June.

President Christophe Piganiol of Zeul...